WebMar 31, 2024 · Bevans MF, Mitchell SA, Barrett AJ, Bishop M, Childs R, Fowler D, Krumlauf M, Prince P, Shelburne N, Wehrlen L. Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol. Health Qual Life Outcomes. 2011 Apr 17;9:24. doi: 10.1186/1477-7525-9-24. WebVol. 11, N 12. P. 945-956. 82. Jagasia M.H. et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report//Biol. Blood Marrow Transplant. Elsevier Inc., 2015. Vol. 21, N 3. P. 389-401. e1.
Comparison Between 5-Azacytidine Treatment and …
WebBiol Blood Marrow Transplant, 2015. doi: 10.1016/j.bbmt.2015.05.010. [Epub ahead of print] [4] ... Biol Blood Marrow Transplant, 2005, 11 (12): 945 – 956. [7] Carpenter PA, Macmillan ML. Management of acute graft-versus-host disease in children [J]. Pediatr Clin North Am, 2010, 57 (1): 273 ... WebDec 26, 2015 · Biol Blood Marrow Transplant 2005;11:945-956. External Resources. Pubmed/Medline (NLM) Crossref (DOI) Konuma T, Ooi J, Takahashi S, Tomonari A, … popeye ghosks in the bunk
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as ...
WebIntroduction. Hematopoietic stem cell transplantation (HSCT) is a curative approach for hematologic malignancies. In general, cord blood transplantation (CBT) is a safe and effective alternative for patients lacking an HLA-matched related or unrelated donor. 1–3 In recent years, with the improvement of transplantation procedures, the use of unrelated … WebDec 12, 2024 · Biol Blood Marrow Transplant 11:945–956. Article PubMed Google Scholar Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A et al (2014) Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transplant 49:168–173 WebFeb 17, 2024 · Biol Blood Marrow Transplant 2005; 11:945. Jagasia M, Giglia J, Chinratanalab W, et al. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol Blood Marrow Transplant 2007; 13:1207. ... Biol Blood Marrow Transplant 2010; 16:1707. Arora M, Klein JP, Weisdorf … share price of rattan power